HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David E Adson Selected Research

olanzapine-fluoxetine combination (Symbyax)

1/2020A preliminary study of resting brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David E Adson Research Topics

Disease

2Treatment-Resistant Depressive Disorder
01/2020 - 08/2008
2Substance Withdrawal Syndrome (Withdrawal Symptoms)
06/2011 - 12/2003
2Anxiety Disorders (Anxiety Disorder)
05/2005 - 01/2004
1Cardiovascular Diseases (Cardiovascular Disease)
04/2013
1Sleepiness
04/2009
1Social Phobia
04/2009
1Depressive Disorder (Melancholia)
01/2004
1Premature Ejaculation
12/2003
1Gambling (Pathological Gambling)
06/2002

Drug/Important Bio-Agent (IBA)

2Paroxetine (Paxil)FDA LinkGeneric
04/2013 - 06/2002
2Quetiapine Fumarate (Seroquel)FDA Link
04/2009 - 01/2004
2Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
05/2005 - 01/2004
1olanzapine-fluoxetine combination (Symbyax)FDA Link
01/2020
1Bupropion (Wellbutrin)FDA LinkGeneric
06/2011
1NicotineFDA Link
06/2011
1Glucose (Dextrose)FDA LinkGeneric
08/2008
1Aripiprazole (Abilify)FDA Link
05/2005
1CitalopramFDA LinkGeneric
12/2003

Therapy/Procedure

4Therapeutics
08/2008 - 12/2003
1Aftercare (After-Treatment)
01/2020
1Vagus Nerve Stimulation
08/2008